CGC
Canopy Growth Corp
NASDAQ: CGC · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$1.11
+1.83% today
Updated 2026-04-30
Market cap
$619.73M
P/E ratio
—
P/S ratio
2.23x
EPS (TTM)
$-1.36
Dividend yield
—
52W range
$1 – $2
Volume
11.0M
Canopy Growth Corp (CGC) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $549.00 | $4488.00 | — | $4144.00 | — | $1.15M | $1.15M | $12.70M | $39.90M | $77.95M | $226.34M | $398.77M | $546.65M | $475.70M | $333.25M | $297.15M | $269.00M |
| Revenue growth (YoY) | — | +717.5% | -100.0% | — | -100.0% | — | +0.0% | +1008.4% | +214.2% | +95.4% | +190.4% | +76.2% | +37.1% | -13.0% | -29.9% | -10.8% | -9.5% |
| Cost of revenue | — | — | — | — | — | $731313.00 | $731313.00 | $-6.29M | $2.26M | $3.76M | $137.41M | $430.46M | $479.69M | $663.11M | $396.78M | $216.26M | $189.48M |
| Gross profit | $549.00 | $4488.00 | — | $4144.00 | — | $414349.00 | $414349.00 | $18.99M | $37.63M | $74.19M | $88.93M | $-31.68M | $66.96M | $-187.41M | $-63.53M | $80.88M | $79.51M |
| Gross margin | 100.0% | 100.0% | — | 100.0% | — | 36.2% | 36.2% | 149.5% | 94.3% | 95.2% | 39.3% | -7.9% | 12.2% | -39.4% | -19.1% | 27.2% | 29.6% |
| R&D | — | — | — | — | — | $159648.00 | $159648.00 | $721000.00 | $810000.00 | $1.45M | $15.24M | $61.81M | $57.58M | $32.26M | $21.72M | $4.61M | $2.73M |
| SG&A | — | — | — | $68752.00 | $739940.00 | $5.75M | $6.00M | $11.67M | $25.59M | $92.92M | $451.44M | $624.91M | $329.45M | $172.66M | $160.63M | $104.44M | $60.85M |
| Operating income | $-26918.00 | $-19580.00 | $-21393.00 | $-64608.00 | $-931657.00 | $-6.74M | $-7.74M | $-2.75M | $-15.21M | $-78.88M | $-553.64M | $-1.67B | $-1.24B | $-1.02B | $-2.63B | $-228.71M | $-117.14M |
| Operating margin | -4903.1% | -436.3% | — | -1559.1% | — | -588.1% | -675.3% | -21.6% | -38.1% | -101.2% | -244.6% | -418.5% | -227.5% | -214.2% | -789.3% | -77.0% | -43.5% |
| EBITDA | $-26918.00 | $-24068.00 | $-26156.00 | $-64608.00 | $-925988.00 | — | $-6.96M | $938000.00 | $-692000.00 | $-29.80M | $-631.83M | $-1.38B | $-449.65M | $-52.98M | $-2.88B | $-312.83M | $-479.31M |
| EBITDA margin | -4903.1% | -536.3% | — | -1559.1% | — | 0.0% | -607.5% | 7.4% | -1.7% | -38.2% | -279.1% | -345.4% | -82.3% | -11.1% | -864.2% | -105.3% | -178.2% |
| EBIT | $-26918.00 | $-19580.00 | $-21393.00 | $-64608.00 | $-930174.00 | $-6.74M | $-7.32M | $-1.32M | $-6.76M | $-50.28M | $-678.75M | $-1.50B | $-576.77M | $-163.92M | $-2.96B | $-366.00M | $-522.43M |
| Interest expense | $26918.00 | $4488.00 | $4763.00 | $0.00 | $1268.00 | $0.00 | $65815.00 | $140000.00 | $66000.00 | $784000.00 | $18.41M | $6.72M | $8.46M | $103.94M | $126.16M | $105.35M | $74.57M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-26918.00 | $-24068.00 | $-21393.00 | $-64608.00 | $-932925.00 | $-8.93M | $-8.93M | $-3.50M | $-16.61M | $-54.13M | $-670.09M | $-1.32B | $-1.74B | $-310.04M | $-3.28B | $-657.27M | $-598.12M |
| Net income growth (YoY) | — | +10.6% | +11.1% | -202.0% | -1344.0% | -857.4% | +0.0% | +60.9% | -375.0% | -226.0% | -1137.8% | -97.2% | -32.1% | +82.2% | -957.3% | +80.0% | +9.0% |
| Profit margin | -4903.1% | -536.3% | — | -1559.1% | — | -779.6% | -779.6% | -27.5% | -41.6% | -69.4% | -296.1% | -331.3% | -319.2% | -65.2% | -983.7% | -221.2% | -222.4% |